Annexon (ANNX) News Today $2.47 -0.23 (-8.52%) Closing price 04:00 PM EasternExtended Trading$2.56 +0.09 (+3.64%) As of 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Annexon (ANNX) to Release Quarterly Earnings on TuesdayMarch 23 at 1:27 AM | americanbankingnews.comAnnexon (ANNX) Projected to Post Earnings on TuesdayAnnexon (NASDAQ:ANNX) will be releasing earnings before the market opens on Tuesday, March 25, Financial Modeling Prep reports.March 18, 2025 | marketbeat.comAnalysts Set Annexon, Inc. (NASDAQ:ANNX) Price Target at $15.80March 16, 2025 | americanbankingnews.comAnnexon, Inc. (NASDAQ:ANNX) Given Average Rating of "Buy" by AnalystsShares of Annexon, Inc. (NASDAQ:ANNX - Get Free Report) have received a consensus recommendation of "Buy" from the six brokerages that are covering the stock, MarketBeat.com reports. Six analysts have rated the stock with a buy rating. The average twelve-month price objective among brokerages thatMarch 13, 2025 | marketbeat.comBank of America Securities Remains a Buy on Annexon Biosciences (ANNX)March 10, 2025 | markets.businessinsider.comAnnexon price target lowered to $11 from $12 at BofAMarch 10, 2025 | markets.businessinsider.comQ1 Earnings Estimate for Annexon Issued By HC WainwrightAnnexon, Inc. (NASDAQ:ANNX - Free Report) - Stock analysts at HC Wainwright issued their Q1 2025 earnings estimates for Annexon in a research note issued on Tuesday, March 4th. HC Wainwright analyst A. Fein expects that the company will post earnings per share of ($0.33) for the quarter. HC WainwMarch 8, 2025 | marketbeat.comCandriam S.C.A. Buys 341,431 Shares of Annexon, Inc. (NASDAQ:ANNX)Candriam S.C.A. lifted its stake in Annexon, Inc. (NASDAQ:ANNX - Free Report) by 15.6% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 2,534,230 shares of the company's stock after purchasing an additional 341,431 sharesMarch 8, 2025 | marketbeat.comCantor Fitzgerald Forecasts Weaker Earnings for AnnexonAnnexon, Inc. (NASDAQ:ANNX - Free Report) - Stock analysts at Cantor Fitzgerald reduced their FY2025 earnings per share estimates for Annexon in a report issued on Tuesday, March 4th. Cantor Fitzgerald analyst P. Stavropoulos now expects that the company will post earnings of ($1.47) per share foMarch 7, 2025 | marketbeat.comQ2 Earnings Estimate for Annexon Issued By HC WainwrightAnnexon, Inc. (NASDAQ:ANNX - Free Report) - Research analysts at HC Wainwright issued their Q2 2025 earnings per share estimates for Annexon in a research report issued on Tuesday, March 4th. HC Wainwright analyst A. Fein anticipates that the company will earn ($0.33) per share for the quarter. HMarch 7, 2025 | marketbeat.comWells Fargo Reaffirms Their Buy Rating on Annexon Biosciences (ANNX)March 4, 2025 | markets.businessinsider.comAnnexon price target lowered to $20 from $30 at H.C. WainwrightMarch 4, 2025 | markets.businessinsider.comAnnexon (NASDAQ:ANNX) Earns Buy Rating from Needham & Company LLCNeedham & Company LLC reiterated a "buy" rating and issued a $16.00 price target on shares of Annexon in a research report on Tuesday.March 4, 2025 | marketbeat.comAnnexon, Inc. (NASDAQ:ANNX) Stock Position Lifted by Mutual of America Capital Management LLCMutual of America Capital Management LLC grew its position in shares of Annexon, Inc. (NASDAQ:ANNX - Free Report) by 56.2% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,029,680 shares of the company'March 4, 2025 | marketbeat.comAnnexon reports Q4 EPS (33c), consensus (29c)March 3, 2025 | markets.businessinsider.comAnnexon (NASDAQ:ANNX) Issues Earnings Results, Misses Expectations By $0.05 EPSAnnexon (NASDAQ:ANNX - Get Free Report) issued its earnings results on Monday. The company reported ($0.33) EPS for the quarter, missing the consensus estimate of ($0.28) by ($0.05).March 3, 2025 | marketbeat.comAnnexon Reports Fourth Quarter and Year-End 2024 Financial Results, Portfolio Progress and Key Anticipated MilestonesMarch 3, 2025 | globenewswire.comAnnexon Biosciences to Present at the TD Cowen 45th Annual Health Care ConferenceFebruary 26, 2025 | globenewswire.comInsider Selling: Annexon, Inc. (NASDAQ:ANNX) Insider Sells 5,521 Shares of StockAnnexon, Inc. (NASDAQ:ANNX - Get Free Report) insider Jamie Dananberg sold 5,521 shares of the business's stock in a transaction on Tuesday, February 18th. The shares were sold at an average price of $2.96, for a total value of $16,342.16. Following the completion of the sale, the insider now owns 33,479 shares in the company, valued at $99,097.84. This represents a 14.16 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this link.February 21, 2025 | marketbeat.comInsider Selling: Annexon, Inc. (NASDAQ:ANNX) EVP Sells 5,515 Shares of StockAnnexon, Inc. (NASDAQ:ANNX - Get Free Report) EVP Dean Richard Artis sold 5,515 shares of Annexon stock in a transaction dated Tuesday, February 18th. The stock was sold at an average price of $2.97, for a total value of $16,379.55. Following the completion of the transaction, the executive vice president now directly owns 83,814 shares of the company's stock, valued at approximately $248,927.58. This trade represents a 6.17 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link.February 21, 2025 | marketbeat.comJennifer Lew Sells 6,912 Shares of Annexon, Inc. (NASDAQ:ANNX) StockAnnexon, Inc. (NASDAQ:ANNX - Get Free Report) CFO Jennifer Lew sold 6,912 shares of the firm's stock in a transaction that occurred on Tuesday, February 18th. The stock was sold at an average price of $2.92, for a total transaction of $20,183.04. Following the sale, the chief financial officer now owns 77,770 shares in the company, valued at $227,088.40. This trade represents a 8.16 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link.February 21, 2025 | marketbeat.comJamie Dananberg Sells 5,521 Shares of Annexon, Inc. (NASDAQ:ANNX) StockFebruary 21, 2025 | insidertrades.comDouglas Love Sells 5,021 Shares of Annexon, Inc. (NASDAQ:ANNX) StockAnnexon, Inc. (NASDAQ:ANNX - Get Free Report) CEO Douglas Love sold 5,021 shares of the business's stock in a transaction that occurred on Thursday, February 13th. The stock was sold at an average price of $2.95, for a total value of $14,811.95. Following the sale, the chief executive officer now owns 351,554 shares of the company's stock, valued at approximately $1,037,084.30. The trade was a 1.41 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.February 19, 2025 | marketbeat.comAnnexon reports inducement grants under Nasdaq listing ruleFebruary 19, 2025 | markets.businessinsider.comAnnexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)February 18, 2025 | globenewswire.comAnnexon, Inc. (NASDAQ:ANNX) Short Interest Up 8.3% in JanuaryAnnexon, Inc. (NASDAQ:ANNX - Get Free Report) was the recipient of a significant increase in short interest in January. As of January 31st, there was short interest totalling 10,090,000 shares, an increase of 8.3% from the January 15th total of 9,320,000 shares. Based on an average trading volume of 1,420,000 shares, the days-to-cover ratio is currently 7.1 days.February 17, 2025 | marketbeat.comAnnexon, Inc. (NASDAQ:ANNX) Given Consensus Recommendation of "Buy" by BrokeragesAnnexon, Inc. (NASDAQ:ANNX - Get Free Report) has earned an average recommendation of "Buy" from the six analysts that are covering the stock, MarketBeat.com reports. Six investment analysts have rated the stock with a buy rating. The average 12-month target price among brokers that have issued raFebruary 16, 2025 | marketbeat.comAnnexon Announces Presentations Highlighting ANX007 Functional and Structural Differentiation in Geographic Atrophy at the Macula Society 48th Annual MeetingFebruary 13, 2025 | globenewswire.comAnnexon stock hits 52-week low at $3.04 amid market challengesFebruary 12, 2025 | msn.comShort Interest in Annexon, Inc. (NASDAQ:ANNX) Increases By 23.7%Annexon, Inc. (NASDAQ:ANNX - Get Free Report) was the target of a significant increase in short interest during the month of January. As of January 15th, there was short interest totalling 8,980,000 shares, an increase of 23.7% from the December 31st total of 7,260,000 shares. Based on an average daily trading volume, of 1,340,000 shares, the short-interest ratio is currently 6.7 days.January 30, 2025 | marketbeat.comCantor Fitzgerald Estimates Annexon FY2025 EarningsAnnexon, Inc. (NASDAQ:ANNX - Free Report) - Research analysts at Cantor Fitzgerald issued their FY2025 earnings estimates for shares of Annexon in a research report issued on Tuesday, January 21st. Cantor Fitzgerald analyst P. Stavropoulos anticipates that the company will earn ($0.99) per shareJanuary 22, 2025 | marketbeat.comAnnexon, Inc. (NASDAQ:ANNX) Given Average Rating of "Buy" by BrokeragesShares of Annexon, Inc. (NASDAQ:ANNX - Get Free Report) have been assigned an average recommendation of "Buy" from the six research firms that are currently covering the stock, MarketBeat reports. Six analysts have rated the stock with a buy recommendation. The average 1-year target price among anJanuary 22, 2025 | marketbeat.comHennion & Walsh Asset Management Inc. Has $2.20 Million Stock Position in Annexon, Inc. (NASDAQ:ANNX)Hennion & Walsh Asset Management Inc. increased its stake in Annexon, Inc. (NASDAQ:ANNX - Free Report) by 65.6% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 429,584 shares of the company's stock aJanuary 18, 2025 | marketbeat.comAnnexon, Inc. (NASDAQ:ANNX) Sees Large Increase in Short InterestAnnexon, Inc. (NASDAQ:ANNX - Get Free Report) was the recipient of a large increase in short interest in the month of December. As of December 31st, there was short interest totalling 8,980,000 shares, an increase of 23.7% from the December 15th total of 7,260,000 shares. Based on an average trading volume of 1,340,000 shares, the short-interest ratio is currently 6.7 days.January 16, 2025 | marketbeat.comBarclays PLC Acquires 120,789 Shares of Annexon, Inc. (NASDAQ:ANNX)Barclays PLC raised its stake in Annexon, Inc. (NASDAQ:ANNX - Free Report) by 212.0% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 177,765 shares of the company's stock after buying an additional 120,789 sharesJanuary 15, 2025 | marketbeat.comAnnexon announces 2025 strategic priorities, key catalystsJanuary 13, 2025 | markets.businessinsider.comAnnexon Provides 2025 Outlook with Strong Momentum Accelerating into Breakthrough YearJanuary 13, 2025 | markets.businessinsider.comJPMorgan Chase & Co. Has $10.10 Million Stake in Annexon, Inc. (NASDAQ:ANNX)JPMorgan Chase & Co. increased its position in shares of Annexon, Inc. (NASDAQ:ANNX - Free Report) by 16.0% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 1,706,182 shares of the company's stock after buying an addiJanuary 13, 2025 | marketbeat.comAnnexon Expands Board of Directors with Appointment of Commercial Executive William “BJ” JonesJanuary 10, 2025 | finance.yahoo.comAnnexon appoints William Jones to board of directorsJanuary 10, 2025 | markets.businessinsider.comAnnexon Biosciences to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceJanuary 7, 2025 | globenewswire.comAnnexon (NASDAQ:ANNX) Stock Price Down 4.3% - What's Next?Annexon (NASDAQ:ANNX) Stock Price Down 4.3% - What's Next?January 6, 2025 | marketbeat.comGeode Capital Management LLC Grows Stake in Annexon, Inc. (NASDAQ:ANNX)Geode Capital Management LLC increased its holdings in shares of Annexon, Inc. (NASDAQ:ANNX - Free Report) by 18.3% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,143,635 shares of the company's stockDecember 31, 2024 | marketbeat.comBarclays PLC Has $1.05 Million Holdings in Annexon, Inc. (NASDAQ:ANNX)Barclays PLC boosted its stake in shares of Annexon, Inc. (NASDAQ:ANNX - Free Report) by 212.0% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 177,765 shares of the company's stock after buying an additional 120December 31, 2024 | marketbeat.comAnnexon, Inc. (NASDAQ:ANNX) Receives Consensus Recommendation of "Buy" from BrokeragesShares of Annexon, Inc. (NASDAQ:ANNX - Get Free Report) have been given a consensus recommendation of "Buy" by the six research firms that are covering the company, MarketBeat Ratings reports. Six analysts have rated the stock with a buy recommendation. The average twelve-month target price amongDecember 28, 2024 | marketbeat.comAnnexon, Inc. (NASDAQ:ANNX) Shares Purchased by State Street CorpState Street Corp raised its stake in Annexon, Inc. (NASDAQ:ANNX - Free Report) by 116.6% during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 3,841,879 shares of the company's stock after purchasing an additional 2,068,2December 23, 2024 | marketbeat.comAnnexon (NASDAQ:ANNX) Trading Down 3.8% - Here's WhyAnnexon (NASDAQ:ANNX) Stock Price Down 3.8% - Here's What HappenedDecember 19, 2024 | marketbeat.comPromising Real-World Evidence Boosts Buy Rating for Annexon’s ANX005 in GBS TreatmentDecember 18, 2024 | markets.businessinsider.comAnnexon's (ANNX) Buy Rating Reiterated at HC WainwrightHC Wainwright restated a "buy" rating and set a $30.00 price target on shares of Annexon in a report on Tuesday.December 17, 2024 | marketbeat.comBuy Rating for Annexon Biosciences: ANX005 Shows Promising Results in GBS TreatmentDecember 17, 2024 | markets.businessinsider.com Remove Ads Get Annexon News Delivered to You Automatically Sign up to receive the latest news and ratings for ANNX and its competitors with MarketBeat's FREE daily newsletter. Email Address ANNX Media Mentions By Week ANNX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ANNX News Sentiment▼0.000.68▲Average Medical News Sentiment ANNX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ANNX Articles This Week▼23▲ANNX Articles Average Week Remove Ads Get Annexon News Delivered to You Automatically Sign up to receive the latest news and ratings for ANNX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies SNDX News Today AUPH News Today SYRE News Today ELVN News Today MLYS News Today NRIX News Today VIR News Today NTLA News Today COLL News Today RCUS News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ANNX) was last updated on 3/25/2025 by MarketBeat.com Staff From Our PartnersYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Annexon, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Annexon With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.